Johnson & Johnson Q3 Results Prompt Mixed Analyst Reactions
Johnson & Johnson reported third-quarter sales of $25.4 billion and non-GAAP EPS of $2.59. The company raised its 2026 sales and non-GAAP EPS guidance, though analysts said parts of the outlook and product mix were disappointing.